Surgical treatment of multiple brain metastases

Journal of Neurosurgery - Tập 79 Số 2 - Trang 210-216 - 1993
Rajesh K. Bindal1, Raymond Sawaya, Milam E. Leavens, John Lee
1Department of Neurosurgery, University of Texas M.D. Anderson Cancer Center, Houston.

Tóm tắt

✓ The authors conducted a retrospective review of the charts of 56 patients who underwent resection for multiple brain metastases. Of these, 30 had one or more lesions left unresected (Group A) and 26 underwent resection of all lesions (Group B). Twenty-six other patients with a single metastasis who underwent resection (Group C) were selected to match Group B by type of primary tumor, time from first diagnosis of cancer to diagnosis of brain metastases, and presence or absence of systemic cancer at the time of surgery. Statistical analysis indicated that Groups A and B were also homogeneous for these prognostic indicators. Median survival duration was 6 months for Group A, 14 months for Group B, and 14 months for Group C. There was a statistically significant difference in survival time between Groups A and B (p = 0.003) and Groups A and C (p = 0.012) but not between Groups B and C (p > 0.5). Brain metastasis recurred in 31% of patients in Group B and in 35% of those in Group C; this difference was not significant (p > 0.5). Symptoms improved after surgery in 65% of patients in Group A, 83% in Group B, and 84% in Group C. Symptoms worsened in 13% of patients in Group A, 6% in Group B, and 0% in Group C. Groups A, B, and C had complication rates per craniotomy of 8%, 9%, and 8%, and 30-day mortality rates of 3%, 4%, and 0%, respectively. Guidelines for management of patients with multiple brain metastases are discussed. The authors conclude that surgical removal of all lesions in selected patients with multiple brain metastases results in significantly increased survival time and gives a prognosis similar to that of patients undergoing surgery for a single metastasis.

Từ khóa


Tài liệu tham khảo

10.3171/jns.1992.76.3.0444

10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E

10.1002/1097-0142(196405)17:5<558::AID-CNCR2820170503>3.0.CO;2-E

10.1016/0360-3016(80)90195-9

10.1002/1097-0142(19901115)66:10<2105::AID-CNCR2820661011>3.0.CO;2-I

Burt M, 1992, J Thorac Cardiovasc Surg, 103, 399, 10.1016/S0022-5223(19)34977-3

10.1007/BF00165714

10.1002/ana.410070606

Cairncross JG, 1983, Oncology of the Nervous System., 341, 10.1007/978-1-4613-3858-1_13

Caron J, 1992, J Neurooncol, 12, 173, 10.1007/BF00172669

10.1002/1097-0142(196306)16:6<781::AID-CNCR2820160614>3.0.CO;2-M

Cox D, 1984, Analysis of Survival Data.

Davis PC, 1991, Am J Neuroradiol, 12, 293

10.1001/archneur.1988.00520310047016

10.1097/00006123-198009000-00006

10.3171/jns.1984.60.3.0621

10.1016/0360-3016(92)90762-7

Galicich JH, 1990, Neurological Surgery, 3, 3204

10.1002/1097-0142(19800115)45:2<381::AID-CNCR2820450232>3.0.CO;2-J

10.1038/bjc.1956.47

Kaplan EL, 1958, J Am Stat Assoc, 53, 475, 10.1080/01621459.1958.10501452

Karnofsky DA, 1949, Evaluation of Chemotherapeutic Agents., 191

Kurtz JM, 1981, Int J Radiat Oncol Biol Phys, 7, 891, 10.1016/0360-3016(81)90005-5

Loeffler JS, 1990, J Clin Oncol, 8, 576, 10.1200/JCO.1990.8.4.576

10.1002/1097-0142(19840601)53:11<2550::AID-CNCR2820531129>3.0.CO;2-B

Markesbery WR, 1978, Arch Neurol, 35, 754, 10.1001/archneur.1978.00500350058012

Oredsson S, 1990, Eur J Surg Oncol, 16, 451

Patchell RA, 1991, Neurol Clin, 9, 817, 10.1016/S0733-8619(18)30250-0

10.1056/NEJM199002223220802

10.1002/1097-0142(196503)18:3<298::AID-CNCR2820180306>3.0.CO;2-H

10.1097/00000421-199010000-00013

10.1002/1097-0142(19850315)55:6<1382::AID-CNCR2820550637>3.0.CO;2-Z

Sze G, 1990, Am J Neuroradiol, 11, 785

Takakura K, 1982, Metastatic Tumors of the Central Nervous System.

Young B, 1990, Neurosurgery Update I: Diagnosis, Operative Technique, and Neuro-Oncology., 473

Thông tin
Thông tin xuất bản

Journal of Neurosurgery

Tập 79 Số 2

210-216

Thông tin tác giả